Health Affairs, 27, no. 1 (2008): 179-187 doi: 10.1377/hlthaff.27.1.179 © 2008 by Project HOPE	New Online   Pay Cuts For Medicare Docs   Access To Care Woes   Public Coverage More Efficient   Empowering Consumers

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Yang, B.-m. Articles by Kim, J. Search for Related Content PubMed PubMed Citation Articles by Yang, B.-m. Articles by Kim, J. Related Collections Business Of Health Health Reform International Issues Pharmaceuticals

Health Tracking

MARKETWATCH

Economic Evaluation And Pharmaceutical Reimbursement Reform In South Korea’s National Health Insurance

South Korea’s National Health Insurance recently announced a reform in pharmaceutical reimbursement, with the purpose of increasing rational resource use in drug spending. The new policy aims to take the cost-effectiveness and budget impact of newly introduced drugs into account in payment decisions. If the policy is implemented, South Korea will be the first Asian country to officially adopt economic evaluation as a tool for resource allocation in health care. This paper looks at the background, objectives, expected outcomes, potential issues, and resulting trade conflict regarding use of economic data in drug reimbursement decisions in South Korea.

                      What's this?